SHOUGANG LANZATECH (02553.HK) has launched its Hong Kong IPO, with the offering period running from May 26 to May 29, 2026. The company plans to globally offer 40,000,000 H Shares, subject to a 15% over-allotment option; the offer price ranges from HK$14.60 to HK$17.10 per share, with each board lot consisting of 200 shares and an entry subscription fee of approximately HK$3,454.49; the shares are expected to be listed on the Main Board of the Hong Kong Stock Exchange on June 3, 2026. Yuexiu Securities Holdings Limited is acting as the sole sponsor.

SHOUGANG LANZATECH: The World’s Largest CCUS Enterprise Utilizing Synthetic Biotechnology

Offering Structure: Hong Kong Public Offering approximately 10% (4,000,000 shares), International Offering approximately 90% (36,000,000 shares).

Offer Price: HK$14.60—17.10 per share; board lot size of 200 shares; entry fee of approximately HK$3,454.49.

Offering Period: May 26—29, 2026 (expected pricing date: June 1, 2026).

Listing Date: June 3, 2026.

IPO Sponsor: Yuexiu Securities Holdings Limited.

Company Overview

SHOUGANG LANZATECH is deeply engaged in the carbon capture, utilization and storage (CCUS) industry, focusing on the production of low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, while also providing integrated low-carbon solutions. According to Frost & Sullivan, by revenue in 2025, the company ranked as the world’s largest enterprise in the CCUS industry utilizing synthetic biotechnology. The company operates four large-scale production facilities across three provinces in China, and its microbial protein product was the first in China to obtain a New Feed and Feed Additive Product Certificate under the feed raw material category.

Financial Information

The prospectus disclosed that SHOUGANG LANZATECH recorded revenue of approximately RMB593 million, RMB564 million and RMB522 million for 2023, 2024 and 2025, respectively, while net losses for the same periods were approximately RMB110 million, RMB246 million and RMB325 million, respectively. Based on the mid-point offer price of HK$15.85 per share and assuming the over-allotment option is not exercised, the company is expected to raise net proceeds of approximately HK$533 million. The proceeds are intended to be used for the construction of the Phase II facility of Hebei Shoulang (approximately 24.5%), construction and development of the SAF production facility in Baotou, Inner Mongolia (approximately 24.8%), R&D relating to strains and production processes (approximately 15.7%), technological upgrades for four production facilities (approximately 14.6%), development of new products (approximately 9.7%), investment in a gas company proposed by the local government of Ningxia Binze (approximately 4.3%), and general working capital and other corporate purposes (approximately 6.4%).

uSMART launches “HK IPO Fee-Waiver Offer” – subscribe to new shares at zero cost

Margin subscription: 0 % interest, leverage up to 10×

Cash subscription: HK$0 handling fee

Grey-market trading supported

* 0 % interest applies to margin subscription amounts of HK$20 million or below.

^ All handling fees are waived for cash subscriptions.

This promotion is effective from 5 December 2025 until further notice. Certain high-profile IPOs may be excluded. The actual interest rates and fees charged are those shown in the uSMART App subscription interface; statutory government and exchange levies will still apply. The company reserves the right to amend, suspend or terminate the above offer or its terms and conditions at any time without prior notice, and its interpretation shall be final.

How to Subscribe for SHOUGANG LANZATECH via uSMART HK

The uSMART HK App features an IPO Centre with exclusive perks, allowing clients to subscribe instantly to public offerings. After logging into the app, tap "Trade" at the bottom-right, go to "IPO Subscription," select SHOUGANG LANZATECH, tap "Public Offer," enter your subscription quantity, and submit your order.

(Image source: uSMART HK App)